Uncategorized

HIV wellness

STAYING FIT & HEALTHY WHILE AGING WITH HIV

Lecture Agenda: Weight Gain in the New HIV Era- Review of Studies Preventing Heart Disease Reducing Visceral Fat Healthy Nutrition Tips Exercise Tips Weight Loss Medications Hormone Balance Sleep- The Pillar of Health Resources Weight Gain in HIV: Then and Now 1996- 2006: Weight gain was characterized by accumulation in the visceral and cervical area …

STAYING FIT & HEALTHY WHILE AGING WITH HIV Read More »

HIV health wellness hormones

HIV and Hormones

Low testosterone is associated with poor health status in men with HIV Use of Testosterone and Anabolic Steroids in Patients Who Have HIV Thread: Longitudinal Changes over 10 years in Free Testosterone … Are persons with HIV worthy of cancer prevention diagnoses and … How to Decrease HIV related belly fat accumulation When to start nandrolone (Decadurabolin) when …

HIV and Hormones Read More »

HIV Activists Seek to Accelerate Development of Immune Enhancing Therapies for Immunologic Non-Responders.

FOR IMMEDIATE RELEASE   For more information: Richard Jefferys Michael Palm Basic Science, Vaccines & Cure Project Director Treatment Action Group [email protected]   Nelson Vergel Program for Wellness Restoration [email protected]       PRESS RELEASE   HIV Activists Seek to Accelerate Development of Immune Enhancing Therapies for Immunologic Non-Responders.   Dialogues with FDA, scientists and …

HIV Activists Seek to Accelerate Development of Immune Enhancing Therapies for Immunologic Non-Responders. Read More »

Low-dose growth hormone therapy reduces inflammation in HIV-infected patients

Randomized controlled trial Lindboe JB, et al. Infect Dis (Lond). 2016 Nov-Dec. Authors Lindboe JB1, Langkilde A1, Eugen-Olsen J2, Hansen BR2,3, Haupt TH1, Petersen J1,4, Andersen O1,3. Author information 1a Optimed, Clinical Research Centre 056, Copenhagen University Hospital Hvidovre , Hvidovre , Denmark ; 2b Clinical Research Centre 056, Copenhagen University Hospital Hvidovre , Hvidovre …

Low-dose growth hormone therapy reduces inflammation in HIV-infected patients Read More »

New Bill Mandates Coverage of HIV Lipodystrophy Treatments

Ben Klein, a Senior Attorney from GLAD.org speaks about the new bill approved in the state of Massachusetts in Aug. 2016 that mandates several insurance carriers in that state to reimburse cost for HIV related lipodystrophy therapies and how activists can advocate for similar bills in other states. California is also trying to get a …

New Bill Mandates Coverage of HIV Lipodystrophy Treatments Read More »

New HIV Medications Being Studied in 2017

Antiretroviral treatment – where we are now / New HIV Drugs & Treatments    from: https://www.natap.org/2017/CROI/croi_151.htm Joseph J. Eron MD Professor of Medicine University of North Carolina at Chapel Hill The CROI meeting in Seattle this year was again a terrific mix of basic, translational, clinical and epidemiological research. This year perhaps we are seeing more clinical …

New HIV Medications Being Studied in 2017 Read More »

Top Ten Testosterone Replacement Monitoring Tips

Nelson Vergel, author of Testosterone: A Man’s Guide (Amazon.com) and founder of ExcelMale.com and DiscountedLabs.com, talks about what he thinks are the most important 10 things that all men on testosterone replacement therapy should know to maximize benefits and minimize side-effects. For questions for Nelson, please register on ExcelMale.com and post them on the forum …

Top Ten Testosterone Replacement Monitoring Tips Read More »

Why Has Only One Person Been Cured of HIV in 10 Years?

In 2006, Timothy Brown, an American living in Berlin,  was on antiretroviral therapy with good viral suppression when he developed leukemia and required bone marrow transplants after other treatment failed. His doctor in Berlin, Gero Hütter, MD, had the idea to use bone marrow from a donor with a double CCR5-delta-32 mutation, meaning the stem …

Why Has Only One Person Been Cured of HIV in 10 Years? Read More »

Reducing HIV-Related Inflammation: Safety Study of Ruxolitinib

Dr Vincent Marconi talks about his study “Evaluating the Safety and Tolerability of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults” which is currently looking for volunteers. For more information about the study or how to join it, call us at 206-744-8883 or email us at [email protected] https://clinicaltrials.gov/ct2/show/N… Dr Vincent Marconi received his MD at the Johns Hopkins …

Reducing HIV-Related Inflammation: Safety Study of Ruxolitinib Read More »